Standard BioTools Inc. (NasdaqGS: LAB) Loss Submission Form

Kuznicki Law is investigating the proposed sale of SomaLogic, Inc. (NasdaqGM: SLGC) to Standard BioTools Inc. (“the Company”) (NasdaqGS: LAB).  Under the terms of the proposed transaction, upon closing of the proposed transaction, Standard BioTools shareholders will own approximately 43% of the combined company. Kuznicki Law is seeking to determine whether the transaction and the process that led to it are adequate and fair to the Company’s shareholders.